1. Home
  2. NKGN

NKGN

NKGen Biotech Inc.

Logo NKGen Biotech Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.

Founded: 2017 Country:
United States
United States
Employees: N/A City: SANTA ANA
Market Cap: 30.6M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 2.9M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -5.05 EPS Growth: N/A
52 Week Low/High: $0.78 - $6.70 Next Earning Date: 05-16-2024
Revenue: $77,000 Revenue Growth: -84.69%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: